Development of Assist Tool for Breast Examination Using the Principle of Ultrasonic Sensor

Key facts

Sponsor

Seoul National University Hospital

Enrollment

200 enrolled

Eligibility

18-80 years · FEMALE

Timeline

2024 – 2025

Study locations (1)

• Seoul National University Hospital, Seoul, South Korea

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Rare malignant breast tumor

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT06523452
  Laser Speckle Imaging During Breast Reconstruction
  Royal Devon and Exeter NHS Foundation Trust
• RECRUITINGPHASE1NCT06239467
  First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer
  OnKure, Inc.
• ACTIVE NOT RECRUITINGPHASE1NCT06206837
  A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.
  Pfizer
• ACTIVE NOT RECRUITINGNANCT06234488
  Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study
  Medical College of Wisconsin
• RECRUITINGPHASE2NCT05601440
  Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
  Canadian Cancer Trials Group
• ENROLLING BY INVITATIONNANCT07206888
  Advanced Ultrasound Signal Processing of Suspicious Breast Images
  Johns Hopkins University
• ACTIVE NOT RECRUITINGPHASE3NCT01674140
  S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
  SWOG Cancer Research Network
• ACTIVE NOT RECRUITINGPHASE3NCT01349322
  Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
  Radiation Therapy Oncology Group

See all trials for Rare malignant breast tumor →